financetom
Business
financetom
/
Business
/
TELUS Q1 Adjusted Net Income Rises 1%; Hikes Dividend, Reiterates 2024 Targets
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
TELUS Q1 Adjusted Net Income Rises 1%; Hikes Dividend, Reiterates 2024 Targets
May 9, 2024 5:00 AM

07:42 AM EDT, 05/09/2024 (MT Newswires) -- TELUS ( TU ) on Thursday reported a small increase in adjusted net income for the first quarter.

The communications technology company booked adjusted net earnings of $390 million, up 1.0% from $386 million in the year-ago quarter. Adjusted earnings per share edged down to $0.26 from $0.27.

Operating revenues and other income slipped to $4.93 billion from $4.96 billion while adjusted EBITDA rose 4.3% to $1.86 billion.

"In the first quarter, our team once again delivered against our differentiated growth strategy, leveraging our superior asset portfolio, consistent execution track record and proactive cost efficiency initiatives to deliver industry-leading customer additions and solid financial results against the backdrop of a dynamic operating environment," President and CEO Darren Entwistle said.

The board declared a quarterly dividend of $0.3891 per share, a 7% increase from the previous year. The dividend is payable July 2 to holders of record at the close of business on June 10.

TELUS ( TU ) reiterated its financial targets for 2024, including adjusted EBITDA growth of 5.5% to 7.5%, consolidated capital expenditures of about $2.6 billion and free cash flow of about $2.3 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Semtech Plans $350 Million Convertible Senior Notes Offering
Semtech Plans $350 Million Convertible Senior Notes Offering
Oct 6, 2025
05:04 PM EDT, 10/06/2025 (MT Newswires) -- Semtech ( SMTC ) said late Monday it intends to offer $350 million in 0% convertible senior notes due 2030 in a private placement. The company may also grant initial purchasers an option to buy up to an additional $52.5 million of notes. The company said it will use the net proceeds and...
Verona Pharma Gets UK Court Approval for $10 Billion Sale to Merck
Verona Pharma Gets UK Court Approval for $10 Billion Sale to Merck
Oct 6, 2025
05:07 PM EDT, 10/06/2025 (MT Newswires) -- Verona Pharma ( VRNA ) said late Monday that the High Court of Justice of England and Wales approved its about $10 billion acquisition by Merck ( MRK ) . Under the deal, Verona shareholders will receive $107 per American Depositary Share, with each ADS representing eight Verona ordinary shares. The transaction is...
KalVista Pharmaceuticals' Interim Trial Data of Ekterly to Treat Hereditary Angioedema Shows Rapid Symptom Relief
KalVista Pharmaceuticals' Interim Trial Data of Ekterly to Treat Hereditary Angioedema Shows Rapid Symptom Relief
Oct 6, 2025
05:08 PM EDT, 10/06/2025 (MT Newswires) -- KalVista Pharmaceuticals ( KALV ) said late Monday that the interim data from ongoing trials of Ekterly to treat hereditary angioedema attacks showed a halt in the progression of attacks and fast symptom relief with a median response time of 20 minutes. The KONFIDENT-S trial data from 69 participants across 15 European countries...
Rocket Lab Sets Launch Window for Synspective Satellite
Rocket Lab Sets Launch Window for Synspective Satellite
Oct 6, 2025
05:09 PM EDT, 10/06/2025 (MT Newswires) -- Rocket Lab ( RKLB ) said the launch window for its next mission for Synspective, a leading synthetic aperture radar satellite data and analytics company from Japan will open on Oct. 14 from New Zealand. The mission will deploy Synspective's seventh new generation StriX satellite, Rocket Lab ( RKLB ) said Monday in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved